AIDS is a deadly syndrome in which Highly Active Anti-retroviral therapy is used to reduce the viral load. However these anti-retroviral drugs are supposed to cause several adverse drug reaction. There are several studies that report anemia with Zidovudine and gastrointestinal symptoms with Lamivudine. In this report, We present a case of a 38 year old female patient suffering from HIV infection who is suspected to drug induced anemia and gastritis due to Zidovudine, Lamivudine and Nevirapine combination (ZLN) regimen. The relationship between the administered drug regimen and the suspected ADR’s was found using causality assessment. Severity, predictability and probability was also found for the suspected ADR’s. We need to monitor the HIV patients who are under ZLN regimen for their blood haemoglobin and gastrointestinal symptoms.
As the COVID-19 has become a pandemic across the globe, the knowledge of healthcare workers (HCWs) about the diseases and its management is very vital to have a better control over the infection. This study was carried out to assess the knowledge of HCWs of the 5 south Indian states with higher rates of COVID-19 infection. An online survey with 25 validated questions about COVID-19 was administered to 385 HCWs across the study region. Prior to the administration, the questionnaire was validated for various standard parameters using Cronbach’s alpha score greater than 0.7. The responses were analyzed using descriptive statistics and statistical significance was assessed using one-way ANOVA.p value of less than 0.05 was considered to be statistically significant. The overall knowledge about COVID-19 was found to be greater among the medical doctors, pharmacists and nurses from higher to lower scores with a mean value of78.81±13.45 compared to the other healthcare workers 63.6±24.3. The one-way ANOVA revealed that the difference in the knowledge levels among the HCWs significantly differed (p=0.0012). The answers to few of the questions were found to be highly dynamic as the advisory guidelines are highly dynamic. The present knowledge level of HCWs in south India about COVID-19 is relatively high. However, there is a need for continuous education about COVID-19 to the HCWs and the national organizations and authorities should provide a structured and reliable information to the HCWs in order to have a better control over the COVID-19 infection.
Pruritis is mostly presented as a warning/symptom of a few chronic diseases that may include kidney diseases. Often it can be an indication of any neurologic, systemic, psychiatric or dermatologic disorders. About 10-70% of patients with chronic renal failure, and patients undergoing dialysis exist with Pruritis. Undiagnosed Pruritis may develop into cellulitis and other complications such as septicemia. A clinical pharmacist role is crucial in managing such patients. Clinical pharmacists’ vital role towards the patient helps them manage the unhealthy condition, restore, and improve their quality of life. We had a case report of anaemia in chronic kidney disease presented with Pruritis. The treatment was going on for the severe anaemic condition. Pruritis was left undiagnosed. The treating physician accepted the intervention of the clinical pharmacist to add Epoetin-alfa 3000 units/mL thrice a week. This intervention reaffirms the role of clinical pharmacists in developing the pharmaceutical care plan for patients.
Background and Aim Medication use management involves a set of regulations and analytical techniques for defining comprehending and assessing medicine prescription distribution and consumption and also evaluating measures to improve the efficacy of these processes. The present study aimed to assess the medication use pattern prevalence and comorbidity conditions associated with cardiovascular diseases CVD.Methods A prospective observational study was conducted for a duration of six months in the inpatient medicine department of Chigateri District hospital Davangere Tertiary care teaching hospital. Two hundred four case reports of patients with CVD were reviewed and details such as demographics specified drugs prescribed Health Related Quality of Life HRQOL were recorded.Result Two hundred four patients were enrolled out of which 57.35 were males and 42.65 were females. Most of the patients were in the age range of 58-67 years. The most prevalent CVD treated was hypertension HTN 28.23 and the most common comorbidity associated was HTN 32.17. Social habits like smoking 13.75 and HTN 16.92 were found to be the most frequent associated risk factors in CVD patients. The most commonly prescribed class of drugs was antiplatelet 28.41 the common prescribed drug was Furosemide 13.39 and Fixed Dose Combination FDC was Ecosprin gold Atorvastatin Clopidogrel Aspirin 35.29. Most of the prescriptions showed polypharmacy 84.31. While assessing the HRQOL physical component summary PCS 56.94 and mental component summary MCS 54.24 were in a modest range.Conclusion The most prevalent type of CVD was HTN. HTN and DM were the prevalent comorbid conditions among the study population. In the study polypharmacy was noted which may have an impact on rationality. Statins and antiplatelet use was appropriate however excessive use of Furosemide must be controlled. Proper prescription writing increases patient treatment compliance which promotes reason.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.